Abstract
Dyspepsia has been defined as chronic recurrent pain or discomfort centered in the upper abdomen, characterized by symptoms of nausea, vomiting, bloating, and early satiety, all of which are usually exacerbated by food intake. Essential features offunctionaldyspepsia include persistent pain or discomfort above the umbilicus, not associated with or relieved by a change of stool frequency or form, as well as a lack of evidence for inflammatory, anatomic, metabolic, or neoplastic conditions. In about 50 % of adults and greater than 70 % of children, the pathophysiology of symptoms of functional dyspepsia is related to abnormalities in the upper gastrointestinal motor function, such as delayed gastric and small intestinal transit, decreased gastric accommodation, and gastric dysrhythmia. Diagnostic evaluation should be driven by an index of clinical suspicion based on pertinent red flags in the history and physical examination. A comprehensive treatment approach uses the biopsychosocial model, which involves a combination of educational, pharmacological, psychological, as well as complementary therapies. Determining the patient’s most distressing symptom may also help to target particular treatment options and individualize therapy. Follow-up of dyspeptic patients at 6 months to 2 years revealed that 70 % of subjects were either asymptomatic or much improved regardless of the cause; however, the remainder had neither improvement nor worsening of their symptoms despite aggressive medical management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Di Lorenzo CR, R Andree, D Forbes, E Guiraldes, J Hyams, A Staiano, LS Walker. Childhood functional gastrointestinal disorders: child/adolescent. In: Drossman DA, editor. Rome III: the functional gastrointestinal disorders, 3rd ed. McLean, VA: Degnon Associates, Inc.; 2006. p. 733–8.
Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr. 1996;129(2):220–6.
Hyams JS, Davis P, Sylvester FA, Zeiter DK, Justinich CJ, Lerer T. Dyspepsia in children and adolescents: a prospective study. J Pediatr Gastroenterol Nutr. 2000; 30(4):413–8.
De Giacomo C, Valdambrini V, Lizzoli F, et al. A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents. Helicobacter. 2002;7(6):356–63.
Talley NJ. Dyspepsia: management guidelines for the millennium. Gut. 2002;50 Suppl 4:iv72–8. discussion iv79.
Youssef NN, Murphy TG, Langseder AL, Rosh JR. Quality of life for children with functional abdominal pain: a comparison study of patients’ and parents’ perceptions. Pediatrics. 2006;117(1):54–9.
Thumshirn M. Pathophysiology of functional dyspepsia. Gut. 2002;51 Suppl 1:i63–6.
Friesen CA, Lin Z, Garola R, et al. Chronic gastritis is not associated with gastric dysrhythmia or delayed solid emptying in children with dyspepsia. Dig Dis Sci. 2005;50(6):1012–8.
Chitkara DK, Delgado-Aros S, Bredenoord AJ, et al. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr. 2003;143(5):609–13.
Chitkara DK, Camilleri M, Zinsmeister AR, et al. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr. 2005;146(4):500–5.
Bisschops R, Karamanolis G, Arts J, et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut. 2008;57(11):1495–503.
Walker MM, Salehian SS, Murray CE, et al. Implications of eosinophilia in the normal duodenal biopsy—an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010;31:1229–36.
Friesen CA, Sandridge L, Andre L, Roberts CC, Abdel-Rahman SM. Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia. Clin Pediatr (Phila). 2006;45(2): 143–7.
Schappi MG, Borrelli O, Knafelz D, et al. Mast cell-nerve interactions in children with functional dyspepsia. J Pediatr Gastroenterol Nutr. 2008;47(4): 472–80.
Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29(7):765–73.
Fried M, Feinle C. The role of fat and cholecystokinin in functional dyspepsia. Gut. 2002;51 Suppl 1:i54–7.
Van Oudenhove L, Vandenberghe J, Geeraerts B, et al. Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med. 2007;69(5):455–63.
Van Oudenhove L, Vandenberghe J, Dupont P, et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol. 2010;105(4):913–24.
Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment—Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003;17(12):1481–91.
Drumm B, Rowland M. The epidemiology of Helicobacter pylori: where to from here? J Pediatr Gastroenterol Nutr. 2003;36(1):7–8.
Raguza D, Machado RS, Ogata SK, Granato CF, Patricio FR, Kawakami E. Validation of a monoclonal stool antigen test for diagnosing Helicobacter pylori infection in young children. J Pediatr Gastroenterol Nutr. 2010;50(4):400–3.
Miele E, Simeone D, Marino A, et al. Functional gastrointestinal disorders in children: an Italian prospective survey. Pediatrics. 2004;114(1):73–8.
Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;4:CD001960.
Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002;50 Suppl 4:iv36–41.
Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001;96(3):689–96.
FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs. 2009.http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm149533.htm. Accessed 27 Apr 2010.
Tack J. Prokinetics and fundic relaxants in upper functional GI disorders. Curr Opin Pharmacol. 2008; 8(6):690–6.
Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol. 1998;93(2): 160–5.
Bouras EP, Talley NJ, Camilleri M, et al. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008;103(8):2043–50.
Friesen CA, Kearns GL, Andre L, Neustrom M, Roberts CC, Abdel-Rahman SM. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr. 2004;38(3):343–51.
Friesen CA, Neilan NA, Schurman JV, Taylor DL, Kearns GL, Abdel-Rahman SM. Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. BMC Gastroenterol. 2009;9:32.
van Tilburg MA, Chitkara DK, Palsson OS, et al. Audio-recorded guided imagery treatment reduces functional abdominal pain in children: a pilot study. Pediatrics. 2009;124(5):e890–7.
Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, Tromp E, Benninga MA. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology. 2007;133(5):1430–6.
Weydert JA, Shapiro DE, Acra SA, Monheim CJ, Chambers AS, Ball TM. Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial. BMC Pediatr. 2006;6:29.
Youssef NN, Rosh JR, Loughran M, et al. Treatment of functional abdominal pain in childhood with cognitive behavioral strategies. J Pediatr Gastroenterol Nutr. 2004;39(2):192–6.
Schurman JV, Wu YP, Grayson P, Friesen CA. A pilot study to assess the efficacy of biofeedback-assisted relaxation training as an adjunct treatment for pediatric functional dyspepsia associated with duodenal eosinophilia. J Pediatr Psychol. 2010;35: 837–47.
Xu S, Hou X, Zha H, Gao Z, Zhang Y, Chen JD. Electroacupuncture accelerates solid gastric emptying and improves dyspeptic symptoms in patients with functional dyspepsia. Dig Dis Sci. 2006;51(12): 2154–9.
Takahashi T. Acupuncture for functional gastrointestinal disorders. J Gastroenterol. 2006;41(5):408–17.
Soo S, Moayyedi P, Deeks J, Delaney B, Lewis M, Forman D. Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2004;3:CD002301.
Melzer J, Rosch W, Reichling J, Brignoli R, Saller R. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther. 2004;20(11–12): 1279–87.
von Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner P. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol. 2007;102(6):1268–75.
Micklefield GH, Redeker Y, Meister V, Jung O, Greving I, May B. Effects of ginger on gastroduodenal motility. Int J Clin Pharmacol Ther. 1999;37(7):341–6.
Ghayur MN, Gilani AH. Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders. Dig Dis Sci. 2005;50(10):1889–97.
Tack JT, NJ, Camilleri M, et al. The functional gastrointestinal disorders: functional dyspepsia. In: Drossman DA, editor. Rome III: the functional gastrointestinal disorders. McLean, VA: Virginia Degnon Associates, Inc.; 2006. p. 426–450.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Leiby, A., Chitkara, D.K. (2013). Functional Dyspepsia. In: Faure, C., Di Lorenzo, C., Thapar, N. (eds) Pediatric Neurogastroenterology. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-709-9_33
Download citation
DOI: https://doi.org/10.1007/978-1-60761-709-9_33
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-708-2
Online ISBN: 978-1-60761-709-9
eBook Packages: MedicineMedicine (R0)